Linezolid | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Linezolid
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Linezolid

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 30 USDMF, 5 JDMF, 21 EU WC, 7 KDMF, 19 NDC API, 47 Listed Suppliers, $ API Reference Price

72 API Suppliers
30 USDMF
5 JDMF
21 EU WC
7 KDMF
19 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 36 FDA Orange Book, 62 Europe, 7 Canada, 19 South Africa, 61 Listed Dossiers

185 FDF Dossiers
36 FDA Orange Book
62 Europe
7 Canada
19 South Africa
61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML), SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG
SOLUTION;INTRAVENOUS - 200MG/100ML (2MG/ML)
SOLUTION;INTRAVENOUS - 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 6 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 2 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 8 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

93 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 50 Disintegrants & Superdisintegrants, 40 Direct Compression, 35 Thickeners and Stabilizers, 34 Granulation, 33 Controlled & Modified Release, 27 Taste Masking, 22 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 20 Solubilizers, 19 Film Formers & Plasticizers, 17 Parenteral, 15 Co-Processed Excipients, 13 Topical, 9 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

93 Fillers, Diluents & Binders
53 Coating Systems & Additives
50 Disintegrants & Superdisintegrants
40 Direct Compression
35 Thickeners and Stabilizers
34 Granulation
33 Controlled & Modified Release
27 Taste Masking
22 Lubricants & Glidants
21 Chewable & Orodispersible Aids
20 Solubilizers
19 Film Formers & Plasticizers
17 Parenteral
15 Co-Processed Excipients
13 Topical
9 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 40 Finished Drug Prices, 8 Annual Reports

3 US Medicaid Prescriptions
40 Finished Drug Prices
8 Annual Reports

MARKET PLACE

45 APIs, 20 FDF Dossiers

45 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 15 Others

1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 780 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Pfizer Canada Inc.

filter Patent Reset all filters

4 All

01 42168560

filter Product Reset all filters

4 All

01 4Linezolid

filter Dosage Reset all filters

4 All

01 1Liquid

02 1Oral Suspension

03 2Tablet

filter Exp Date Reset all filters

4 All

01 42014-08-16

Product Main Page

01

Pfizer Canada Inc.

Linezolid

PharmScience R&D

Not Confirmed

Pfizer Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 400mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Linezolid

PharmScience R&D

Not Confirmed

Pfizer Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 600mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Linezolid

PharmScience R&D

Not Confirmed

Pfizer Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 2 mg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : I.V.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Linezolid

PharmScience R&D

Not Confirmed

Pfizer Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Brand Name : ZYVOXAM

Patent Number : 2168560

Filing Date : 1994-08-16

Strength per Unit : 100mg / 5ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-08-16

Date Granted : 2001-08-14

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!